OCULAR IMMUNOLOGY AND INFLAMMATION

Scope & Guideline

Illuminating the path to understanding ocular inflammation.

Introduction

Explore the comprehensive scope of OCULAR IMMUNOLOGY AND INFLAMMATION through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore OCULAR IMMUNOLOGY AND INFLAMMATION in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0927-3948
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1993 to 2024
AbbreviationOCUL IMMUNOL INFLAMM / Ocul. Immunol. Inflamm.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal "Ocular Immunology and Inflammation" is dedicated to advancing the understanding of ocular inflammatory diseases and their immune responses. It encompasses a wide range of topics, including clinical management, pathophysiology, and innovative treatment approaches.
  1. Ocular Inflammatory Diseases:
    The journal focuses on various ocular inflammatory diseases, particularly uveitis, scleritis, and related conditions, examining their etiology, clinical features, and management strategies.
  2. Immune Response Mechanisms:
    Research articles explore the immunological mechanisms underlying ocular inflammation, including the roles of cytokines, autoantibodies, and genetic predispositions.
  3. Innovative Therapeutics:
    The journal promotes research on new therapeutic approaches, including biologics and immunomodulatory therapies, aimed at improving patient outcomes in ocular inflammatory diseases.
  4. Diagnostic Advances:
    A significant emphasis is placed on advancements in diagnostic techniques, such as optical coherence tomography (OCT) and angiography, to enhance the detection and monitoring of ocular inflammation.
  5. Epidemiological Studies:
    The journal includes studies investigating the epidemiology and demographic trends associated with ocular inflammatory conditions, providing insights into prevalence and risk factors.
Recent publications in "Ocular Immunology and Inflammation" reflect emerging trends and themes that are gaining traction among researchers. These areas highlight the evolving landscape of ocular inflammatory disease research.
  1. Impact of COVID-19 on Ocular Health:
    The COVID-19 pandemic has spurred a significant increase in studies examining its effects on ocular health, including post-vaccination inflammatory responses and ocular manifestations of the virus.
  2. Role of Artificial Intelligence in Diagnosis:
    There is a rising interest in the application of artificial intelligence and machine learning for diagnosing and managing ocular inflammatory diseases, indicating a shift towards technology-driven approaches.
  3. Microbiome and Ocular Inflammation:
    Research exploring the relationship between the ocular microbiome and inflammatory diseases is gaining momentum, with studies investigating how microbial profiles influence disease onset and progression.
  4. Personalized Medicine Approaches:
    There is an increasing focus on personalized medicine in treating ocular inflammatory conditions, with research aimed at tailoring therapies based on individual patient profiles and responses.
  5. Long-term Outcomes and Quality of Life:
    Emerging research is placing greater emphasis on long-term outcomes and quality of life assessments in patients with ocular inflammatory diseases, highlighting the importance of holistic care.

Declining or Waning

As the field evolves, certain research areas may see a decline in focus or publication frequency. The following themes appear to be waning in prominence in recent publications.
  1. Traditional Pharmacotherapy:
    There is a noticeable decrease in studies focusing solely on traditional pharmacotherapy for ocular inflammation, as newer biologic therapies gain prominence.
  2. Invasive Diagnostic Procedures:
    Research focusing on invasive diagnostic techniques, such as anterior chamber paracentesis or vitrectomy solely for diagnostic purposes, is becoming less common as non-invasive imaging modalities advance.
  3. Single-Cause Inflammatory Theories:
    The trend towards attributing ocular inflammation to single pathogens or causes is declining, with a growing recognition of multifactorial and autoimmune contributions.

Similar Journals

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Unveiling the Science Behind Sight
Publisher: SPRINGERISSN: 0721-832XFrequency: 12 issues/year

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, published by Springer, has established itself as a premier journal in the field of ophthalmology since its inception in 1870. With an ISSN of 0721-832X and an E-ISSN of 1435-702X, this esteemed journal enjoys a notable impact in the research community, ranking Q1 in Ophthalmology and Q1 in Sensory Systems, as per the latest 2023 journal category quartiles. GRAEFES Archive is dedicated to advancing our understanding of ocular health through both clinical and experimental studies, making it an essential resource for researchers, practitioners, and students alike. Its comprehensive scope covers various aspects of ophthalmic science, reflecting its long-standing commitment to quality and excellence. Although it currently operates on a subscription basis, the journal's significant Scopus rankings—24th out of 137 in Ophthalmology—underscore its relevance and influence within the scientific community. Situated in Germany, with its address in the United States, this international journal continues to shape the discourse on vision science and therapeutic innovation.

Expert Review of Ophthalmology

Pioneering Innovations in Ophthalmology
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1746-9899Frequency: 6 issues/year

Expert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.

OPHTHALMIC RESEARCH

Connecting Researchers for a Brighter Future in Eye Health
Publisher: KARGERISSN: 0030-3747Frequency: 6 issues/year

Ophthalmic Research, with ISSN 0030-3747 and E-ISSN 1423-0259, is a distinguished peer-reviewed journal published by Karger in Switzerland. Established in 1970, this journal serves as a vital resource for exploration and dissemination of knowledge within the fields of Ophthalmology, Cellular and Molecular Neuroscience, and Sensory Systems, maintaining its relevance through its convergence into modern research methodologies leading up to 2024. With impressive rankings in 2023, it holds a Q2 quartile in both Ophthalmology and Medicine (miscellaneous), reflecting its significant contribution to the academic community, alongside Scopus ranks that position it favorably in the competitive landscape of medical and neuroscientific literature. Although not open access, the journal ensures that high-quality research remains accessible to its readership, which includes researchers, professionals, and students eager to stay at the forefront of ophthalmic advancements. By fostering interdisciplinary collaboration and facilitating high-level discourse, Ophthalmic Research is pivotal for those committed to advancing the future of eye care and vision sciences.

Ocular Oncology and Pathology

Illuminating the Intersection of Vision and Disease
Publisher: KARGERISSN: 2296-4681Frequency: 6 issues/year

Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Journal of Ophthalmic & Vision Research

Exploring Innovations in Eye Health
Publisher: KNOWLEDGE EISSN: 2008-2010Frequency: 4 issues/year

The Journal of Ophthalmic & Vision Research, published by KNOWLEDGE E, stands as a crucial platform for disseminating high-quality research in the field of ophthalmology. With an ISSN of 2008-2010 and an E-ISSN of 2008-322X, this journal fosters open access to valuable insights since 2010, enhancing visibility and reach for researchers globally. Based in Dubai, UAE, it has established a reputation for excellence, reflected in its Q2 ranking in Ophthalmology for 2023 and its position among the top 65th percentile in Scopus. Covering a broad spectrum of topics within ophthalmic science, the journal serves as a vital resource for professionals, researchers, and students by presenting original research, reviews, and case studies that drive innovation and collaboration within the community. As the journal continues to contribute to advancements in eye care and vision sciences, it invites scholars to explore, engage, and publish within its pages, thus enriching the global discourse on ophthalmic health.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Transforming vision care with cutting-edge studies.
Publisher: MARY ANN LIEBERT, INCISSN: 1080-7683Frequency: 10 issues/year

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, published by Mary Ann Liebert, Inc, stands at the forefront of research in the realms of ophthalmology and pharmacology. Established in 1985 and converging until 2024, this esteemed journal is dedicated to advancing the understanding of ocular pharmacology, drug therapies, and therapeutic approaches in the treatment of eye diseases. With an impressive impact factor and categorized in the Q2 quartile for both Ophthalmology and Medical Pharmacology, it showcases pivotal research in the field, reflecting its rank of #31 among 137 in Ophthalmology and #109 among 272 in Medical Pharmacology per Scopus metrics. Although it follows a subscription-based model, the journal provides critical insights and empirical studies that foster innovation and collaboration for researchers, professionals, and students alike in the pursuit of improving ocular health.

Journal of Ophthalmology

Unlocking New Perspectives in Ophthalmic Studies
Publisher: HINDAWI LTDISSN: 2090-004XFrequency: 1 issue/year

The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.

International Journal of Ophthalmology

Advancing Vision Through Innovative Research
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

EXPERIMENTAL EYE RESEARCH

Exploring the Frontiers of Visual Mechanisms
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0014-4835Frequency: 12 issues/year

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

MOLECULAR VISION

Empowering researchers to illuminate the field of ocular science.
Publisher: MOLECULAR VISIONISSN: 1090-0535Frequency: 1 issue/year

MOLECULAR VISION is a premier open-access journal that has been advancing the field of ophthalmology since its inception in 1995. Published by MOLECULAR VISION, this journal boasts a strong reputation, currently ranking in the second quartile (Q2) of its category, with a Scopus ranking of 35 out of 137, placing it in the 74th percentile among peer publications. Dedicated to disseminating groundbreaking research and innovative findings in the study of vision and ocular health, MOLECULAR VISION serves as a vital resource for researchers, healthcare professionals, and students engaged in this dynamic field. The journal welcomes contributions spanning fundamental and clinical research, offering a platform for crucial knowledge exchange that is essential for advancing ocular health and function. With its commitment to open access, readers around the globe can freely access and build upon the wealth of information disseminated through its pages, ensuring that the latest developments in ophthalmology are available to all.